O
CL icon

OppenheimerFunds’s Colgate-Palmolive CL Stock Holding History

OppenheimerFunds’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$401M Buy
5,855,519
+142,293
+2% +$9.19M 0.5% 48
2018
Q4 		$340M Sell
5,713,226
-1,031,093
-15% -$64.5M 0.49% 49
2018
Q3 		$452M Sell
6,744,319
-41,668
-0.6% -$2.78M 0.52% 38
2018
Q2 		$440M Buy
6,785,987
+405,430
+6% +$26.5M 0.52% 36
2018
Q1 		$457M Buy
6,380,557
+206,753
+3% +$14.9M 0.57% 36
2017
Q4 		$466M Buy
6,173,804
+166,537
+3% +$12.2M 0.56% 35
2017
Q3 		$438M Sell
6,007,267
-51,063
-0.8% -$3.68M 0.54% 37
2017
Q2 		$449M Sell
6,058,330
-824,789
-12% -$61.2M 0.55% 35
2017
Q1 		$504M Buy
6,883,119
+13,521
+0.2% +$946K 0.61% 27
2016
Q4 		$450M Buy
6,869,598
+35,638
+0.5% +$2.44M 0.57% 32
2016
Q3 		$507M Buy
6,833,960
+128,898
+2% +$9.53M 0.64% 25
2016
Q2 		$491M Buy
6,705,062
+500,217
+8% +$35.6M 0.64% 27
2016
Q1 		$438M Buy
6,204,845
+305,801
+5% +$20.3M 0.58% 37
2015
Q4 		$393M Sell
5,899,044
-89,602
-1% -$5.96M 0.5% 48
2015
Q3 		$380M Buy
5,988,646
+318,290
+6% +$20.8M 0.51% 41
2015
Q2 		$371M Buy
5,670,356
+216,830
+4% +$14.7M 0.43% 53
2015
Q1 		$378M Buy
5,453,526
+9,710
+0.2% +$671K 0.42% 56
2014
Q4 		$377M Buy
5,443,816
+6,070
+0.1% +$410K 0.42% 59
2014
Q3 		$355M Buy
5,437,746
+15,960
+0.3% +$1.05M 0.39% 63
2014
Q2 		$370M Buy
5,421,786
+135,260
+3% +$9.07M 0.41% 60
2014
Q1 		$343M Sell
5,286,526
-34,420
-0.6% -$2.17M 0.4% 59
2013
Q4 		$347M Sell
5,320,946
-5,381,646
-50% -$344M 0.42% 54
2013
Q3 		$635M Buy
10,702,592
+4,186,718
+64% +$248M 0.42% 55
2013
Q2 		$373M Buy
+6,515,874
New +$387M 0.54% 35

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

OppenheimerFunds's CL Position: Q1 2019 in Review

OppenheimerFunds increased its Colgate-Palmolive (CL) stake by 2.5% in Q1 2019, buying an estimated $9.19M and bringing the position to 5,855,519 shares worth $401M. The position accounts for 0.5% of the portfolio, ranked #48.

OppenheimerFunds first reported a position in CL in Q2 2013 and has held it in 24 quarters since. The position peaked at $635M in Q3 2013. 1,447 funds tracked by Wall St. Rank hold CL as of Q1 2019.

  • OppenheimerFunds held 5,855,519 shares of Colgate-Palmolive worth $401M as of Q1 2019.
  • OppenheimerFunds bought 142,293 Colgate-Palmolive shares in Q1 2019, an estimated $9.19M.
  • Colgate-Palmolive made up 0.5% of OppenheimerFunds's portfolio in Q1 2019, its #48 holding.
  • OppenheimerFunds first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Colgate-Palmolive position peaked at $635M in Q3 2013.
  • 1,447 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.